Synopsis
Synopsis
0
USDMF
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Ampicillin Pivaloyl Ester
2. Berocillin
3. Ester, Ampicillin Pivaloyl
4. Hydrochloride, Pivampicillin
5. Monohydrochloride, Pivampicillin
6. Pivamiser
7. Pivampicillin Hydrochloride
8. Pivampicillin Monohydrochloride
9. Pondocillin
1. Pivaloylampicillin
2. 33817-20-8
3. Pivaloyloxymethyl Ampicillinate
4. Pivampicilina
5. Pivampicilline
6. Pivampicillinum
7. Ampicillin Pivaloyloxymethyl Ester
8. Pivampicilina [inn-spanish]
9. Pivampicilline [inn-french]
10. Pivampicillinum [inn-latin]
11. Pivampicillin (inn)
12. 0hlm346ll7
13. Chebi:8255
14. 2,2-dimethylpropanoyloxymethyl (2s,5r,6r)-6-[[(2r)-2-amino-2-phenylacetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate
15. Mk-191
16. Pivampicillin [inn]
17. Dsstox_cid_25459
18. Dsstox_rid_80890
19. Dsstox_gsid_45459
20. 2,2-dimethylpropanoyloxymethyl (2s,5r,6r)-6-[(2-amino-2-phenylacetyl)amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate
21. Pivampicillin [inn:ban]
22. Mk 191
23. Pondocillin (tn)
24. Einecs 251-688-6
25. Unii-0hlm346ll7
26. Ncgc00016823-01
27. Cas-33817-20-8
28. Prestwick0_001009
29. Prestwick1_001009
30. Prestwick2_001009
31. Prestwick3_001009
32. Pivampicillin [mi]
33. Schembl34182
34. Bspbio_001137
35. 4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic Acid, 6-((aminophenylacetyl)amino)-3,3-dimethyl-7-oxo-, (2,2-dimethyl-1-oxopropoxy)methyl Ester, (2s-(2alpha,5alpha,6beta(s*)))-
36. Pivampicillin [mart.]
37. Spbio_003018
38. Pivampicillin [who-dd]
39. Bpbio1_001251
40. Chembl3182343
41. Dtxsid1045459
42. Hms1571i19
43. Hms2098i19
44. Hms3715i19
45. Pivampicillin [ep Monograph]
46. Tox21_110631
47. Zinc34967244
48. Tox21_110631_1
49. Ccg-221009
50. Db01604
51. Ncgc00179290-01
52. Ncgc00179290-03
53. [(2,2-dimethylpropanoyl)oxy]methyl 6beta-[(2r)-2-amino-2-phenylacetamido]-2,2-dimethylpenam-3alpha-carboxylate
54. 4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic Acid, 6-(2-amino-2-phenylacetamido)-3,3-dimethyl-7-oxo-, Hydroxymethyl Ester, Pivalate (ester), D-(-)-
55. Ab00513999
56. D08396
57. Sr-01000872693
58. Q3122143
59. Sr-01000872693-1
60. (2s,5r,6r)-pivaloyloxymethyl 6-((r)-2-amino-2-phenylacetamido)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate
61. {[(2s,5r,6r)-6-[(2r)-2-amino-2-phenylacetamido]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptan-2-yl]carbonyloxy}methyl 2,2-dimethylpropanoate
62. 4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic Acid, 6-((aminophenylacetyl)amino)-3,3-dimethyl-7-oxo-, (2,2-dimethyl-1-oxopropoxy)methyl Ester (2s-(2.alpha.,5.alpha.,6.beta.(s*)))-
63. Hydroxymethyl D-(-)-6-(2-amino-2-phenylacetamido)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylate Pivalate (ester)
Molecular Weight | 463.5 g/mol |
---|---|
Molecular Formula | C22H29N3O6S |
XLogP3 | 2.9 |
Hydrogen Bond Donor Count | 2 |
Hydrogen Bond Acceptor Count | 8 |
Rotatable Bond Count | 9 |
Exact Mass | 463.17770683 g/mol |
Monoisotopic Mass | 463.17770683 g/mol |
Topological Polar Surface Area | 153 Ų |
Heavy Atom Count | 32 |
Formal Charge | 0 |
Complexity | 774 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 4 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
or the treatment of respiratory tract infections (including acute bronchitis, acute exacerbations of chronic bronchitis and pneumonia); ear, nose and throat infections; gynecological infections; urinary tract infections (including acute uncomplicated gonococcal urethritis) when caused by non penicillinase-producing susceptible strains of the following organisms: gram-positive organisms, e.g., streptococci, pneumococci and staphylococci; gram-negative organisms, e.g., H. influenzae, N. gonorrhoeae, E. coli, P. mirabilis.
Pivampicillin is the pivaloyloxymethyl ester of (the semi-synthetic penicillin) ampicillin. It is an inactive pro-drug, which is converted during its absorption from the gastrointestinal tract to the microbiologically active ampicillin, together with formaldehyde and pivalic acid, by non-specific esterases present in most body tissues. Amounts in excess of 99% of the pivampicillin absorbed are converted to ampicillin within 15 minutes of absorption.
Anti-Bacterial Agents
Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)
J - Antiinfectives for systemic use
J01 - Antibacterials for systemic use
J01C - Beta-lactam antibacterials, penicillins
J01CA - Penicillins with extended spectrum
J01CA02 - Pivampicillin
Absorption
Absorbed following oral administration.
Approximately 1 hour.
Ampicillin (the active metabolite of pivampicillin) has a bactericidal action resulting from inhibition of cell wall mucopeptide biosynthesis.
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?